BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6159376)

  • 1. Assessment of inhibitors with chromogenic substrates.
    Latallo ZS
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():48-9. PubMed ID: 6159376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the antiplasmin activity of platelets with a chromogenic substrate].
    Campo G; Ciaffoni S
    Quad Sclavo Diagn; 1985 Sep; 21(3):360-9. PubMed ID: 3835576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised reference curve for the alpha 2-antiplasmin assay by the addition of detergents.
    Kluft C; Wijngaards G; van Voorthuizen H
    Thromb Haemost; 1984 Apr; 51(2):297. PubMed ID: 6740561
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of increased thrombotic tendency with chromogenic substrates].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):135-41. PubMed ID: 6177594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the immediate plasmin inhibition assay to secure linearity of the reference curve with the chromogenic substrate S-2251.
    Jespersen J; Gram J; Sidelmann J
    Thromb Haemost; 1984 Apr; 51(2):298. PubMed ID: 6740562
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional activities and concentrations of plasmin inhibitors in normal subjects and D.I.C. patients.
    Velasco F; Torres A; Andres P; Duran MI
    Thromb Haemost; 1982 Jun; 47(3):275-7. PubMed ID: 6180498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on tissue thromboplastic activity assay method with chromogenic substrates (S-2222)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1984 Mar; 32(3):313-6. PubMed ID: 6737742
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible diagnostic value of aminopeptidases detected by chromogenic substrates in Enterobacteriaceae.
    Giammanco G; Pignato S; Agodi A
    Microbiologica; 1983 Oct; 6(4):355-8. PubMed ID: 6664309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methods of studying alpha 2-antiplasmin activity].
    Boiadzhiian KhP
    Vopr Med Khim; 1991; 37(5):92-4. PubMed ID: 1722061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of chromogenic substrate in cerebrospinal fluid diagnosis].
    Cullmann W; Dick W; Müller N
    Fortschr Neurol Psychiatr; 1983 Jul; 51(7):255-8. PubMed ID: 6194090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alpha-1 antitrypsin, alpha-2-macroglobulin and antiplasmin activity in liver and bile tract diseases].
    Bogdal J; Cichecka K; Jedrychowski A
    Pol Tyg Lek; 1973 Jun; 28(26):969-72. PubMed ID: 4727608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of fibrinolysis with peptide substrates].
    Teger-Nilsson AC; Eriksson E; Gyzander E; Medegard A; Risberg B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):121-34. PubMed ID: 6177593
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heparin and fibrinolysis inhibitors].
    Villaverde CA; Badimón L; Vidal M; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):97-100. PubMed ID: 7325724
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of a new fibrinolysis inhibitor by chromogenic substrates: the fast antiplasmin (author's transl)].
    Diaz-Cremades JM; Vicente JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
    Sangre (Barc); 1978; 23(3):347-57. PubMed ID: 675457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.